… Eligible patients were recommended to undergo allogeneic hematopoietic stem
cell … patients who underwent allogeneic hematopoietic stem cell transplantation was 70% (…
A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX
Published: 11/01/2024